Daniel Glaubiger

3.1k total citations · 1 hit paper
49 papers, 2.5k citations indexed

About

Daniel Glaubiger is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daniel Glaubiger has authored 49 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 18 papers in Oncology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daniel Glaubiger's work include Sarcoma Diagnosis and Treatment (11 papers), DNA and Nucleic Acid Chemistry (9 papers) and Cancer therapeutics and mechanisms (8 papers). Daniel Glaubiger is often cited by papers focused on Sarcoma Diagnosis and Treatment (11 papers), DNA and Nucleic Acid Chemistry (9 papers) and Cancer therapeutics and mechanisms (8 papers). Daniel Glaubiger collaborates with scholars based in United States, Malaysia and India. Daniel Glaubiger's co-authors include Kurt W. Kohn, Warren E. Ross, A Ramu, Z Fuks, David G. Poplack, Ian Magrath, Michael J. Waring, John S. Holcenberg, Charles A. Friedman and James H. Wood and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Daniel Glaubiger

49 papers receiving 2.4k citations

Hit Papers

Qualitative and quantitat... 1979 2026 1994 2010 1979 50 100 150 200

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Daniel Glaubiger 1.2k 1.0k 436 254 231 49 2.5k
S. E. Salmon 1.7k 1.4× 1.9k 1.9× 424 1.0× 189 0.7× 337 1.5× 78 3.9k
F. M. Schabel 1.1k 0.9× 1.2k 1.2× 365 0.8× 209 0.8× 153 0.7× 59 2.9k
David A. Van Echo 916 0.8× 1.5k 1.5× 437 1.0× 132 0.5× 322 1.4× 71 3.0k
H. M. Pinedo 1.4k 1.2× 1.9k 1.9× 361 0.8× 182 0.7× 346 1.5× 101 3.4k
Paul Calabresi 1.3k 1.1× 885 0.9× 445 1.0× 200 0.8× 217 0.9× 105 3.1k
Stanley P. Balcerzak 1.2k 1.0× 1.1k 1.1× 535 1.2× 70 0.3× 379 1.6× 105 3.7k
Schabel Fm 766 0.6× 941 0.9× 335 0.8× 169 0.7× 175 0.8× 60 2.1k
Raymond W. Klecker 810 0.7× 848 0.8× 199 0.5× 132 0.5× 218 0.9× 41 2.4k
William R. Vogler 1.3k 1.1× 710 0.7× 189 0.4× 147 0.6× 141 0.6× 107 3.1k
Michael Colvin 977 0.8× 834 0.8× 182 0.4× 174 0.7× 104 0.5× 67 2.5k

Countries citing papers authored by Daniel Glaubiger

Since Specialization
Citations

This map shows the geographic impact of Daniel Glaubiger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Glaubiger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Glaubiger more than expected).

Fields of papers citing papers by Daniel Glaubiger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Glaubiger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Glaubiger. The network helps show where Daniel Glaubiger may publish in the future.

Co-authorship network of co-authors of Daniel Glaubiger

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Glaubiger. A scholar is included among the top collaborators of Daniel Glaubiger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Glaubiger. Daniel Glaubiger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glaubiger, Daniel, et al.. (2015). The Relative Tolerance of Children and Adults to Anticancer Drugs. Frontiers of radiation therapy and oncology. 16. 42–49. 1 indexed citations
2.
Pierquin, B, Jean‐Jacques Mazeron, & Daniel Glaubiger. (1986). Conservative treatment of breast cancer in Europe: Report of the Group Européen de Curiethérapie. Radiotherapy and Oncology. 6(3). 187–198. 58 indexed citations
3.
Trigg, Michael E., Robert Makuch, & Daniel Glaubiger. (1985). Actuarial risk of isolated cns involvement in Ewing's sarcoma following prophylactic cranial irradiation and intrathecal methotrexate. International Journal of Radiation Oncology*Biology*Physics. 11(4). 699–702. 20 indexed citations
4.
Ungerleider, Richard S., C B Pratt, John S. Holcenberg, et al.. (1985). Phase I trial of mitoxantrone in children.. PubMed. 69(4). 403–7. 15 indexed citations
5.
Ramu, A, Daniel Glaubiger, & Z Fuks. (1984). Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxifen and other triparanol analogues.. PubMed. 44(10). 4392–5. 166 indexed citations
6.
Ramu, A, Daniel Glaubiger, & Hadassa Weintraub. (1984). Differences in lipid composition of doxorubicin-sensitive and -resistant P388 cells.. PubMed. 68(4). 637–41. 53 indexed citations
7.
Glaubiger, Daniel, et al.. (1983). Intensive combined modality therapy including low-dose TBI in high-risk ewing's sarcoma patients. International Journal of Radiation Oncology*Biology*Physics. 9(12). 1955–1960. 32 indexed citations
8.
Srinivasan, Usha, Gregory H. Reaman, David G. Poplack, Daniel Glaubiger, & C. Elizabeth Shaaban. (1982). Phase II study of 5-azacytidine in sarcomas of bone. American Journal of Clinical Oncology. 5(4). 411–416. 9 indexed citations
9.
Dwyer, A J, et al.. (1982). The radiographic follow-up of patients with Ewing sarcoma: a demonstration of a general method.. Radiology. 145(2). 327–331. 3 indexed citations
10.
Riccardi, Riccardo, Bruce A. Chabner, Daniel Glaubiger, James H. Wood, & David G. Poplack. (1982). Influence of tetrahydrouridine on the pharmacokinetics of intrathecally administered 1-beta-D-arabinofuranosylcytosine.. PubMed. 42(5). 1736–9. 6 indexed citations
11.
Cohen, Lawrence F., Kenneth H. Kraemer, Haywood L. Waters, Kurt W. Kohn, & Daniel Glaubiger. (1981). DNA crosslinking and cell survival in human lymphoid cells treated with 8-methoxypsoralen and long wavelength ultraviolet radiation. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 80(2). 347–356. 15 indexed citations
12.
Jentzsch, K., Henry J. Binder, Daniel Glaubiger, et al.. (1981). Leg function after radiotherapy for Ewing's sarcoma. Cancer. 47(6). 1267–1278. 69 indexed citations
13.
Kraemer, Kenneth H., Haywood L. Waters, Lawrence F. Cohen, et al.. (1981). Effects of 8-Methoxypsoralen and Ultraviolet Radiation on Human Lymphoid Cells in Vitro. Journal of Investigative Dermatology. 76(2). 80–87. 33 indexed citations
14.
Simon, Richard, et al.. (1980). HÆMOPOIETIC RECOVERY IN EWING'S SARCOMA AFTER INTENSIVE COMBINATION THERAPY AND AUTOLOGOUS MARROW INFUSION. The Lancet. 316(8191). 385–389. 23 indexed citations
15.
Glaubiger, Daniel, et al.. (1980). Result of attempted hematopoietic reconstitution using isologous, peripheral blood mononuclear cells: a case report. Blood. 56(3). 516–520. 79 indexed citations
16.
Ross, Warren E., Daniel Glaubiger, & Kurt W. Kohn. (1979). Qualitative and quantitative aspects of intercalator-induced DNA strand breaks. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 562(1). 41–50. 216 indexed citations breakdown →
17.
Hoff, Von, et al.. (1978). Phase I study of methanesulfonamide, N-[4-(9-acridinylamino)-3-methoxyphenyl]-(m-AMSA) using a single-dose schedule.. PubMed. 62(10). 1421–6. 34 indexed citations
18.
Wakelin, Laurence P. G., et al.. (1978). Structural limitations on the bifunctional intercalation of diacridines into DNA. Biochemistry. 17(23). 5057–5063. 92 indexed citations
19.
Kohn, Kurt W., Michael J. Waring, Daniel Glaubiger, & Charles A. Friedman. (1975). Intercalative binding of ellipticine to DNA.. PubMed. 35(1). 71–6. 127 indexed citations
20.
Glaubiger, Daniel & John E. Hearst. (1967). Effect of superhelical structure on the secondary structure of DNA rings. Biopolymers. 5(8). 691–696. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026